Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Rousselle

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Hygiene and Environmental Health|April 16, 2021
Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and BelgiumEva Ougier, Karine Fiore, Christophe Rousselle, et al.
Nanotoxicology|March 20, 2018
Assessment of the in vitro genotoxicity of TiO<sub>2</sub> nanoparticles in a regulatory contextSandrine Charles, Stéphane Jomini, Valérie Fessard, et al.
World Neurosurgery|August 18, 2015
Role of Endoscopic Third Ventriculostomy in the Management of Myelomeningocele-Related Hydrocephalus: A Retrospective Study in a Single French InstitutionPierre-Aurelien Beuriat, Alexandru Szathmari, Blandine Grassiot, et al.
Contact Dermatitis|September 8, 2022
Sensitization properties of acetophenone azine, a new skin sensitizer identified in textileIsabelle Manière, Alizée Aubert, Céline Dubois, et al.
International Journal of Hygiene and Environmental Health|October 12, 2020
Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessmentPetra Apel, Christophe Rousselle, Rosa Lange, et al.
Acta Neurochirurgica|June 24, 2021
Management of Chiari type I malformation: a retrospective analysis of a series of 91 children treated surgicallyThéo Broussolle, Pierre Aurélien Beuriat, Alexandru Szathmari, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 21, 2011
Treatment of Chiari type I malformation in children: the experience of LyonCarmine Mottolese, Alexandru Szathmari, Emile Simon, et al.
Toxics|February 24, 2022
Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients-A Case Study of Benzophenone-3Christophe Rousselle, Matthieu Meslin, Tamar Berman, et al.
World Neurosurgery|September 5, 2017
Complete Reversibility of the Chiari Type II Malformation After Postnatal Repair of MyelomeningocelePierre-Aurélien Beuriat, Alexandru Szathmari, Christophe Rousselle, et al.
International Journal of Hygiene and Environmental Health|March 12, 2021
The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizerRosa Lange, Petra Apel, Christophe Rousselle, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Hygiene and Environmental Health|April 16, 2021
Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and BelgiumEva Ougier, Karine Fiore, Christophe Rousselle, et al.
Nanotoxicology|March 20, 2018
Assessment of the in vitro genotoxicity of TiO<sub>2</sub> nanoparticles in a regulatory contextSandrine Charles, Stéphane Jomini, Valérie Fessard, et al.
World Neurosurgery|August 18, 2015
Role of Endoscopic Third Ventriculostomy in the Management of Myelomeningocele-Related Hydrocephalus: A Retrospective Study in a Single French InstitutionPierre-Aurelien Beuriat, Alexandru Szathmari, Blandine Grassiot, et al.
Contact Dermatitis|September 8, 2022
Sensitization properties of acetophenone azine, a new skin sensitizer identified in textileIsabelle Manière, Alizée Aubert, Céline Dubois, et al.
International Journal of Hygiene and Environmental Health|October 12, 2020
Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessmentPetra Apel, Christophe Rousselle, Rosa Lange, et al.
Acta Neurochirurgica|June 24, 2021
Management of Chiari type I malformation: a retrospective analysis of a series of 91 children treated surgicallyThéo Broussolle, Pierre Aurélien Beuriat, Alexandru Szathmari, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 21, 2011
Treatment of Chiari type I malformation in children: the experience of LyonCarmine Mottolese, Alexandru Szathmari, Emile Simon, et al.
Toxics|February 24, 2022
Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients-A Case Study of Benzophenone-3Christophe Rousselle, Matthieu Meslin, Tamar Berman, et al.
World Neurosurgery|September 5, 2017
Complete Reversibility of the Chiari Type II Malformation After Postnatal Repair of MyelomeningocelePierre-Aurélien Beuriat, Alexandru Szathmari, Christophe Rousselle, et al.
International Journal of Hygiene and Environmental Health|March 12, 2021
The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizerRosa Lange, Petra Apel, Christophe Rousselle, et al.
Pageof 7